RxSight, Inc.

RXSTNASDAQHealthcare● Active

$4.95

$-0.05(-1.00%)

Market Cap$204913210

P/E Ratio—

52W High$16

52W Low$4.7

Avg Volume752K

Open$5.00

Beta1.13

Net Income Financials Revenue

RxSight, Inc. (RXST) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

RXST · net income · updated Jun 8, 2026

Core profitability metrics

RXST · net income · margin · TTM · CAGR

Net income was −$38.9M for FY2025 (fiscal year ending 2025-12-31), down 41.8% year-over-year. Net profit margin was -29.0%. Based on available data, RxSight, Inc. has been profitable since at least 2019.

FY2025 Net Income−$38.9M▼ -41.8% YoY

Trailing 12M (TTM)−$46.6Mtrailing 4 quarters sum

Net Profit Margin-29.0%−$38.9M ÷ $134.5M

YoY Change-41.8%—

5-Year CAGRN/AN/A — contains loss years

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 8, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %★ First Profit: 2019

▸ FMP /income-statement · Annual · RXST net income history · RXST profit margin

Annual net income data

RXST · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2025Loss−$38.9M▼ 41.8%-29.0%$134.5M

FY2024Loss−$27.5M▲ +43.5%-19.6%$139.9M

FY2023Loss−$48.6M▲ +27.2%-54.6%$89.1M

FY2022Loss−$66.8M▼ 37.1%-136.2%$49.0M

FY2021Loss−$48.7M▼ 276.6%-215.5%$22.6M

Net income vs peers (Healthcare)

RXST vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

RxSight, Inc.YOU

RXST

−$38.9M-41.8%-29.0%

Loss

Eli Lilly and Company

LLY

$20.64B+94.9%31.7%

77%

UnitedHealth Group Incorporated

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

RxSight, Inc. (RXST) reported net income of −$38.9M for FY2025 (fiscal year ending 2025-12-31), down 41.8% year-over-year. The net profit margin was -29.0% — meaning the company kept $-0.29 of every dollar of revenue as profit.

Based on available data, RxSight, Inc. has been profitable since at least 2019. Net income reached a peak of $126.2M in FY2019. Data available for 7 fiscal years.

RxSight, Inc.'s net profit margin was -29.0% for FY2025, based on the latest annual results.

Investors sometimes search for "RxSight, Inc. net worth" — the company's market capitalization is a separate figure from RXST net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

RXST net income · 4 questions

RxSight, Inc. is not currently profitable on an annual basis. The company reported a net loss of $38.9M for FY2025.

is RXST profitabledoes RXST make a profitRXST profitabilityRXST profitable company

▸ Source: FMP /income-statement · GAAP · RxSight, Inc. · RxSight, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026